focus -WSS

focus

author：Wikipedia 2025-08-28 08:39:49 - browse：66

Illustration of a person talking with a huge speech bubble over his head. -- health tech coverage from STAT — Mike Reddy for STAT

The health care sector is a notorious laggard when it comes to technology. It was slow to use computers, digitize patient data, and share information electronically. While most of the world instantly interacts via Zoom and Slack, hospitals — even today — are still sending faxes.

But something different is happening with generative AI.

Health systems, drugmakers, and insurers are racing to build the technology into their operations, aligning themselves with corporate giants such as Microsoft, Google, and Nvidia, whose executives speak about each incremental advancement of AI as an earth-shattering event. “The generative AI revolution is here,” Jensen Huang, 61, Nvidia’s leather-jacket-clad CEO, declared during the company’s GTC conference in San Jose, Calif., last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： AltruBio raises $225 million to develop ulcerative colitis drug

WSS

Empower primary care with adequate payments and technology

A new drug could help frostbite victims avoid its ravages

Black vets could get higher VA benefits if race not used in lung test

Medicare Advantage enrollment hits roughly 33.4 million

Warren pushes Witty on UnitedHealth's control over physicians

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Wikipedia

focus

explore

The cancer drug shortage isn’t new — and neither are the solutions

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Dobbs anniversary: the lost opportunity of abortion as health care

Chemotherapy before breast cancer surgery might fuel metastasis

Activists slam private health insurers over coverage restrictions

Hospitals are piloting generative AI tools as regulators play catch

Drug repurposing or repositioning? The language matters

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Dobbs anniversary: the lost opportunity of abortion as health care

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

hotspot

Weight loss drugs aren’t covered by Obamacare. That may change

Welsh Carson private equity firm escapes from FTC antitrust case

Can gargling with Listerine treat gonorrhea of the mouth?

Novel spinal cord stimulator treats paralysis without surgery

The creative science of coining drug names

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

focus

hotspot

explore

hotspot